Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00006086 · ClinicalTrials.gov registry record · Phase 1
BMS-188797 and Carboplatin in Treating Patients With Advanced Nonhematologic Cancer
A Phase 1 study, sponsored by H. Lee Moffitt Cancer Center and Research Institute.
- Completed
- Registry status
- Phase 1
- Development phase
NCT00006086: Completed Phase 1 study, sponsored by H. Lee Moffitt Cancer Center and Research Institute.
NCT00006086 is a Phase 1 study that has completed, run by H. Lee Moffitt Cancer Center and Research Institute. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00006086, a Phase 1 study, has completed, sponsored by H. Lee Moffitt Cancer Center and Research Institute.
- COMPLETED
- Registry status
- Phase 1
- Development phase
Study Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. PURPOSE: Phase I trial to study the effectiveness of BMS-188797 and carboplatin in treating patients who have advanced nonhematologic cancer.
Interventions
- DRUG carboplatin
- DRUG BMS-188797
Trial Details
| Field | Value |
|---|---|
| Start Date | 2000-06 |
| Phase | Phase 1 |
What the finished NCT00006086 record still lists
NCT00006086 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 2 interventions - of which carboplatin is the first listed.
NCT00006086 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00006086 about?
NCT00006086 is a clinical study titled "BMS-188797 and Carboplatin in Treating Patients With Advanced Nonhematologic Cancer". RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. PURPOSE: Phase I trial to study the effectiveness of BMS-188797 and carboplatin in treating patients who have advanced nonh...
What is the current status of trial NCT00006086?
This trial is currently completed. It is a Phase 1 study. The study started on 2000-06.
What interventions are being tested in trial NCT00006086?
The interventions under investigation include: carboplatin (DRUG), BMS-188797 (DRUG).
Who is sponsoring clinical trial NCT00006086?
This trial is sponsored by H. Lee Moffitt Cancer Center and Research Institute, which has 502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia